Initial results of a new antibody-drug conjugate (ADC), IMMU-130 (labetuzumab-SN38), in patients with metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Segal, N. H.; Verghis, J.; Govindan, S.; Maliakal, P.; Sharkey, R. M.; Wegener, W. A.; Goldenberg, D. M.; Saltz, L. B. |
| Abstract Title: | Initial results of a new antibody-drug conjugate (ADC), IMMU-130 (labetuzumab-SN38), in patients with metastatic colorectal cancer (mCRC) |
| Meeting Title: | 17th European Cancer Conference (ECCO 17) |
| Journal Title: | European Journal of Cancer |
| Volume: | 49 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2013 Sep 27-Oct 1 |
| Meeting Location: | Amsterdam, Netherlands |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2013-09-01 |
| Start Page: | S545 |
| End Page: | S546 |
| Language: | English |
| ACCESSION: | WOS:000326843603414 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(13)70063-7 |
| Notes: | Meeting Abstract: 2359 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
